IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Scope & Guideline

Advancing the Frontiers of Allergy and Immunology

Introduction

Welcome to the IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0889-8561
PublisherW B SAUNDERS CO-ELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1987 to 2024
AbbreviationIMMUNOL ALLERGY CLIN / Immunol. Allerg. Clin. North Am.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899

Aims and Scopes

The journal 'Immunology and Allergy Clinics of North America' aims to provide a comprehensive overview of the latest advancements in the field of immunology and allergy. Its focus encompasses a wide range of topics, from clinical management to emerging therapeutic approaches, with a strong emphasis on understanding the underlying mechanisms of allergic diseases.
  1. Clinical Evaluation and Management of Allergic Conditions:
    The journal emphasizes the importance of accurate diagnosis and effective management of various allergic conditions, including urticaria, angioedema, and eosinophilic gastrointestinal diseases.
  2. Pathophysiological Insights into Allergic Disorders:
    A significant focus is placed on exploring the underlying pathophysiology of allergic diseases, including the role of mast cells, eosinophils, and environmental factors in disease manifestation.
  3. Emerging Therapeutics and Treatment Strategies:
    The journal highlights the development and evaluation of new therapeutic options for allergic conditions, including biologics and novel pharmacologic agents.
  4. Impact of Environmental Factors on Allergy:
    Research on the influence of climate change and environmental exposures on allergic diseases is a key area, reflecting the growing concern about the impact of these factors on public health.
  5. Pediatric and Special Populations in Allergy:
    There is a consistent focus on the unique aspects of allergic disorders in pediatric patients, pregnant women, and other special populations, emphasizing tailored management strategies.
Recent publications in 'Immunology and Allergy Clinics of North America' indicate a dynamic evolution of research themes, with several emerging and trending areas gaining prominence. These trends reflect the journal's responsiveness to the evolving landscape of allergy and immunology research.
  1. Eosinophilic Gastrointestinal Diseases:
    Recent issues have highlighted a surge in research on eosinophilic gastrointestinal diseases, reflecting increased recognition of their clinical significance and the need for specialized management strategies.
  2. Climate Change and Allergy:
    A growing body of literature is dedicated to exploring the intersections between climate change and allergic diseases, underscoring the urgent need to understand environmental impacts on health.
  3. Quality of Life and Economic Impact Studies:
    There is an expanding focus on assessing the quality of life and economic implications of allergic diseases, indicating a broader interest in patient-centered outcomes and healthcare costs.
  4. Diversity and Inclusion in Allergy Research:
    Emerging discussions around diversity, equity, and inclusion in allergy research highlight the importance of addressing health disparities and ensuring that research benefits all populations.
  5. Novel Therapeutics and Precision Medicine:
    The journal is increasingly publishing on innovative therapeutic strategies, including precision medicine approaches tailored to individual patient profiles, reflecting advancements in the field.

Declining or Waning

While the journal has consistently covered a broad array of topics within immunology and allergy, certain themes have shown a decline in prominence over recent years. This waning focus may reflect shifts in research priorities or emerging challenges within the field.
  1. Traditional Allergen Immunotherapy:
    There appears to be a decreasing emphasis on traditional allergen immunotherapy methods, as newer biologic therapies and precision medicine approaches gain traction.
  2. Generalized Allergy Management Approaches:
    The journal has moved away from generalized discussions on allergy management in favor of more specialized and nuanced topics, indicating a trend towards personalized medicine.
  3. Basic Immunology Without Clinical Context:
    Papers focusing solely on basic immunological mechanisms without direct clinical relevance are less frequent, suggesting a shift towards clinically applicable research.
  4. Historical Perspectives on Allergy:
    There is a noticeable reduction in publications that review historical perspectives or foundational topics in allergy, as contemporary issues and advancements take precedence.

Similar Journals

Allergy Asthma & Immunology Research

Transforming findings into clinical excellence.
Publisher: KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGYISSN: 2092-7355Frequency: 6 issues/year

Allergy Asthma & Immunology Research, published by the Korean Academy of Asthma Allergy & Clinical Immunology, is a leading journal dedicated to advancing the fields of immunology, allergy, and respiratory medicine. With an ISSN of 2092-7355 and an E-ISSN of 2092-7363, this esteemed publication has been a cornerstone for researchers and practitioners since its inception in 2009 and continues to disseminate critical findings through till 2024. The journal is ranked in the Q3 category in Immunology and the Q2 category in Immunology and Allergy as well as Pulmonary and Respiratory Medicine, illustrating its impact in these vital fields. With a solid Scopus ranking in multiple sub-disciplines, the journal not only contributes to the scientific discourse but also promotes innovative research and clinical practices. Although currently operating without an open access model, the journal remains highly regarded for its thorough peer-review process and commitment to academic excellence, making it an essential resource for professionals, researchers, and students passionate about advancing knowledge in allergy, asthma, and immunology.

Frontiers in Allergy

Transforming understanding of allergic disorders.
Publisher: FRONTIERS MEDIA SAISSN: Frequency:

Frontiers in Allergy is a pioneering open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the frontiers of research in the fields of Immunology and Infectious Diseases. Launched in 2020 and based in Lausanne, Switzerland, this journal provides a dynamic platform for researchers, professionals, and students to share innovative findings and insights related to allergic disorders and their broader immunological implications. With a respectable Q2 ranking in both Immunology and Allergy and Infectious Diseases categories, as well as being indexed in Scopus, this journal is emerging as a significant resource for the scientific community. The open-access model ensures wide dissemination of valuable knowledge, facilitating collaboration and breakthroughs in treatments and understanding of allergies and related conditions. Frontiers in Allergy invites contributions that drive forward the understanding of immune responses, allergy prevention, and management, solidifying its role as a crucial player in the sustainability and growth of health sciences.

ALLERGOLOGY INTERNATIONAL

Transforming the landscape of allergy science.
Publisher: JAPANESE SOC ALLERGOLOGYISSN: 1323-8930Frequency: 4 issues/year

ALLERGOLOGY INTERNATIONAL is a prestigious, peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Published by the Japanese Society of Allergology, this Open Access journal has been democratizing knowledge since 1996, providing a platform for the latest findings and clinical practices in the management of allergic diseases. Its impressive Q1 ranking in both Immunology and Allergy** and **Medicine (miscellaneous)** categories in 2023 highlights its significance in the global scientific community, with a commendable Scopus ranking of #31 out of 233 in the field of immunology. The journal's focus on innovative research, comprehensive reviews, and case studies ensures that it remains a vital resource for researchers, healthcare professionals, and students alike. Situated in Tokyo, Japan, it continues to bridge gaps in allergy-related health information and foster international collaboration among scholars.

Allergy Asthma & Respiratory Disease

Bridging science and practice in respiratory medicine.
Publisher: KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGYISSN: 2288-0402Frequency: 4 issues/year

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.

ALLERGY AND ASTHMA PROCEEDINGS

Pioneering the future of Allergy and Asthma treatments.
Publisher: OCEAN SIDE PUBLICATIONS INCISSN: 1088-5412Frequency: 6 issues/year

ALLERGY AND ASTHMA PROCEEDINGS, published by Ocean Side Publications Inc, is a vital resource in the fields of Immunology, Allergy, and Pulmonary Medicine. With an impressive trajectory of publication from 1996 to 2024, this journal serves as a platform for cutting-edge research and advancements in the understanding of allergic and asthmatic conditions. Positioned in the Q3 quartile for Immunology and Allergy and Q2 for both Medicine (miscellaneous) and Pulmonary Medicine, the journal exhibits a robust impact within the academic community, boasting Scopus rankings that reflect its significance. The journal offers open access options, allowing for the dissemination of critical findings to a wider audience. Aimed at researchers, healthcare professionals, and students alike, ALLERGY AND ASTHMA PROCEEDINGS addresses the complexities of respiratory diseases and facilitates the sharing of knowledge that is essential to improving patient care and outcomes.

ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY

Championing high-quality research in allergy and immunology.
Publisher: ALLERGY IMMUNOL SOC THAILANDISSN: 0125-877XFrequency: 4 issues/year

The ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, published by the Allergy Immunology Society of Thailand, is a pivotal platform for disseminating high-quality research in the fields of allergy and immunology. Established in 1983, this journal has consistently evolved to address the pressing challenges and advancements in these dynamic disciplines, contributing significantly to the global scientific community's understanding of immunological disorders. With a category ranking of Q3 in Immunology and Allergy, and Q2 in Medicine (miscellaneous) for 2023, the journal stands at the forefront of impactful research, engaging with a diverse audience of researchers, clinicians, and students alike. Although it operates on a non-open access model, its rigorous peer-review process ensures that published articles meet the highest academic standards. Located in Bangkok, Thailand, the journal connects researchers across the Asia-Pacific region, fostering collaboration and innovation to enhance patient care in the realm of allergy and immunology.

Revue Francaise d Allergologie

Advancing Allergy Research for Tomorrow's Innovations
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1877-0320Frequency: 8 issues/year

The Revue Francaise d'Allergologie, an esteemed publication in the field of Immunology and Allergy, is published by ELSEVIER MASSON, CORP OFF in France. This journal plays a pivotal role in disseminating significant findings and advancements in allergy research and immunotherapy, reflecting the latest trends and challenges in these rapidly evolving areas. As part of its commitment to scholarly rigor, the journal encompasses a wide range of topics pertinent to allergology, aiming to bridge the gap between clinical practice and academic research. Although currently not listed as open access, it provides critical insights essential for researchers, professionals, and students alike, ensuring the advancement of knowledge and therapeutic strategies in allergy and immunology. With its impact factor and positioning in the Q4 category, it serves as a valuable resource, aiding in the education and development of future leaders in the field. The Revue Francaise d'Allergologie continues to be a vital platform for the exchange of innovative ideas and findings from 2009 to the present.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Elevating knowledge in allergy and clinical immunology.
Publisher: MOSBY-ELSEVIERISSN: 0091-6749Frequency: 12 issues/year

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, published by MOSBY-ELSEVIER, stands as a leading peer-reviewed journal dedicated to advancing the understanding of allergies and immunological conditions. With a notable impact factor and a prominent stature in the academic community, it ranks in the Q1 category for both Immunology and Allergy in 2023, reflecting its significance and high citation rates among researchers. Since its establishment in 1963, the journal has fostered scientific discourse and innovation in the field, positioning itself as an essential resource for both seasoned professionals and emerging scholars. The Scopus rankings underscore its influence, being ranked 12th out of 233 in Immunology and Allergy and 15th out of 236 in Immunology and Microbiology, placing it in the top centile of both categories. The journal aims to disseminate cutting-edge research, reviews, and clinical studies that deepen our understanding of allergic diseases and enhance patient care. While not an open access journal, it provides institutions and individuals with opportunities to stay informed on crucial advancements in the immunological sciences.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Innovating Understanding of Allergic Responses and Immune Mechanisms
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

World Allergy Organization Journal

Elevating Standards in Allergy Research and Treatment
Publisher: ELSEVIERISSN: 1939-4551Frequency: 12 issues/year

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.